| 2002 |
T. gondii PKG is an essential protein; genetic disruption of the PKG locus is only achievable when a complementing copy is provided in trans. A catalytic site substitution (T761Q or T761M) renders PKG refractory to compound 1 (trisubstituted pyrrole inhibitor) without affecting other kinase properties, confirming PKG as the primary molecular target of this antiparasitic compound. |
Genetic disruption with trans-complementation; active-site mutagenesis; recombinant expression; in vitro kinase assay; mouse infection model |
Eukaryotic cell |
High |
12455981
|
| 2002 |
T. gondii PKG exists as two isoforms: isoform-I (~110 kDa, membrane-associated) and isoform-II (slightly smaller, cytosolic). Isoform-II arises from alternative translational initiation at an internal methionine codon. Membrane association of isoform-I is mediated by N-terminal myristoylation at G2 and palmitoylation at C4. A putative third allosteric cGMP-binding site unique to apicomplexan PKGs is functionally significant; mutation of this site markedly reduces cGMP-dependent kinase activity in transiently transfected parasites. |
Targeted mutagenesis of translational initiation sites; metabolic labeling; immunofluorescence; in vitro kinase activity assays with transiently transfected parasites |
Molecular and biochemical parasitology |
High |
11897122
|
| 2017 |
PKGI (plasma membrane-associated isoform) is necessary and fully sufficient for all PKG-dependent cellular processes (microneme secretion, motility, invasion, egress), whereas PKGII (cytosolic isoform) is functionally insufficient and dispensable when PKGI is present. The first 15 residues of PKGI, including a myristoylated Gly2, are critical for membrane association and PKG function; swapping this N-terminal region abolishes function. |
Auxin-inducible degron (AID) conditional depletion; CRISPR-Cas9 genome editing; isoform-specific rescue constructs; N-terminal mutagenesis; invasion/egress assays |
mBio |
High |
28465425
|
| 2016 |
Microneme secretion in T. gondii is centrally controlled by PKG in a cGMP-dependent manner. Serum albumin, a host protein, triggers microneme secretion by elevating cGMP and activating PKG independently of elevated intracellular Ca2+; Ca2+ elevation augments but is not required for PKG-dependent secretion. PKG also controls a downstream Ca2+ release from a neutral intracellular store distinct from the ER. |
Genetically encoded Ca2+ indicators (GCaMPs); genetically encoded microneme secretion reporter; pharmacological manipulation (zaprinast, PKG inhibitor); conditional PKG mutant parasites |
The Journal of biological chemistry |
High |
26933037
|
| 2016 |
PKG controls a Ca2+ pool derived from a neutral intracellular store (distinct from the ER) in T. gondii. Two novel ATP-mimetic compounds were identified as PKG inhibitors that prevent zaprinast-induced cytosolic Ca2+ elevation. |
Genetically encoded Ca2+ indicator (GCaMP) cell-based screen; pharmacological inhibition with zaprinast; compound library screening; Ca2+ store characterization |
The Journal of biological chemistry |
Medium |
26933036
|
| 2017 |
PKG acts downstream of PKA in controlling egress: inhibition of PKG blocks premature egress induced by PKAc1 inactivation or environmental acidification. PKAc1 inactivation alters phosphorylation of a putative cGMP-phosphodiesterase, and a cGMP-PDE inhibitor circumvents egress repression by PKAc1 or pH neutralization, placing PKA-cGMP-PKG in a crosstalk pathway governing egress. |
Conditional knockdown (PKAr, PKAc1); phosphoproteomics; pharmacological inhibition of PKG; PDE inhibitor treatment; egress assays |
The EMBO journal |
High |
29030485
|
| 2019 |
PKG (together with CDPK1) controls phosphorylation-dependent regulation of the FRM1-initiated apical F-actin flux essential for T. gondii motility, invasion, and egress. This flux is independent of microneme secretion. |
F-actin chromobody live imaging; gene disruption of FRM1, myosins A/H; pharmacological inhibition of PKG and CDPK1; motility/invasion/egress assays |
eLife |
Medium |
30753127
|
| 2019 |
The upstream guanylate cyclase TgATPaseP-GC (a plasma membrane-localized protein with coupled P4-ATPase and guanylate cyclase domains) is required for cGMP synthesis; Cre/loxP-mediated knockdown of TgATPaseP-GC reduces cGMP levels and recapitulates the motility-defective egress/invasion phenotypes of TgPKG knockdown, placing TgATPaseP-GC upstream of PKG in the cGMP signaling pathway. |
CRISPR/Cas9-assisted disruption; Cre/loxP conditional knockdown; cGMP measurement; phenotypic comparison of TgATPaseP-GC and TgPKG knockdown parasites; IFA localization |
Life science alliance |
Medium |
31235476
|
| 2024 |
The PDK1 ortholog SPARK regulates the stability of PKG (and PKA) protein levels in T. gondii; SPARK depletion leads to down-regulation of PKG and PKA before phenotypic defects appear, placing SPARK upstream of PKG in the AGC kinase signaling hierarchy. |
Conditional genetics (SPARK depletion); unbiased quantitative proteomics; epistasis analysis of PKG/PKA protein levels after SPARK loss |
eLife |
Medium |
39136687
|
| 2025 |
PKG operates within a positive feedback loop with CDPKs to control motility, invasion, and egress in T. gondii. PKAc1 counteracts this PKG/CDPK pathway. PKAc1 acts on targets between guanylate cyclase and Ca2+ release (i.e., upstream of Ca2+ release but downstream of cGMP production), as shown by perturbation of cGMP vs. Ca2+ in the context of PKAc1 manipulation. PKAc1 also activates PDE2 to consume cAMP in a negative feedback loop that transiently limits its own activity. |
Conditional genetic manipulation of PKAc1, PKG, CDPKs; pharmacological perturbation of cGMP and Ca2+; epistasis analysis; egress/motility assays |
Cell reports |
Medium |
39903669
|
| 2006 |
The catalytic site hydrophobic pocket of T. gondii PKG mediates binding of imidazopyridine inhibitors through specific contacts analogous to those in CDPK1; analogous amino acid substitutions in this pocket (e.g., T761Q) abolish compound binding to both PKG and CDPK1, establishing the structural basis of inhibitor selectivity. |
Radiolabeled ligand binding assay with parasite extracts; amino acid sequence comparison; site-directed mutagenesis; transgenic parasite lines expressing compound-refractory PKG (T761Q-KO) |
Molecular and biochemical parasitology |
Medium |
16765465
|
| 2022 |
Time-resolved phosphoproteomics following PKG activation mapped the downstream waves of phosphoregulation in T. gondii, identifying specific proteins phosphorylated upon PKG-dependent signaling. This approach corroborated known physiological roles of PKG and identified novel substrates operating in these pathways. |
Time-resolved phosphoproteomics after PKG activation; thermal proteome profiling |
eLife |
Medium |
35976251
|